ATH 25.0% 0.3¢ alterity therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-36

  1. 50 Posts.
    lightbulb Created with Sketch. 8

    hi Scott

    Firstly, absolutely no to consolidation for me. It would be the worst outcome for holders. I dont read too much on the price action at the moment. This will play out in q1 2025. As for the cash burn, they are running a double blind RCT concurrent to a open label study. Of course they are spending money. These things are not cheap.
    as for someone knowing something and selling, 0 chance. The study is blinded to all, even ATH. imo, this sp is the result of someone who took cap raise shares and atho options getting slammed in multiple positions across the asx and needing cash fast.

    fwiw I loaded up on ATHO today.

    Last edited by Mateo335: Yesterday, 22:11
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $309.3K 102.2M

Buyers (Bids)

No. Vol. Price($)
46 69348011 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 29671017 8
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.